Teza Capital Management LLC Neurocrine Biosciences Inc Transaction History

Teza Capital Management LLC

$645 Million
Q4 2024

A detailed history of Teza Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Teza Capital Management LLC holds 17,864 shares of NBIX stock, worth $1.92 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

17,864

Previous 17,099 4.47%

Holding current value

$1.92 Million

Previous $1.97 Million 23.88%

% of portfolio

0.38%

Previous 0.22%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$111.62 - $139.44 $85,389 - $106,671	765 Added 4.47%	17,864 $2.44 Million
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $808,361 - $1.08 Million	7,055 Added 70.24%	17,099 $1.97 Million
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $701,278 - $767,355	5,359 Added 114.39%	10,044 $1.38 Million
Q1 2024 May 15, 2024	SELL	$130.4 - $143.74 $122,184 - $134,684	-937 Reduced 16.67%	4,685 $646,000
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $763,704 - $955,871	-7,200 Reduced 56.15%	5,622 $740,000
Q3 2023 Feb 22, 2024	BUY	$94.02 - $117.1 $293,060 - $365,000	3,117 Added 55.44%	8,739 $983,000
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $1.21 Million - $1.5 Million	12,822 New	12,822 $1.44 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $1.23 Million - $1.61 Million	-13,047 Reduced 83.15%	2,644 $267,000
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $1.18 Million - $1.4 Million	11,039 Added 237.3%	15,691 $1.87 Million
Q3 2022 Nov 14, 2022	BUY	$92.03 - $107.81 $428,123 - $501,532	4,652 New	4,652 $494,000
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $627,636 - $882,124	-6,527 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $233,657 - $357,968	2,746 Added 72.63%	6,527 $796,000
Q1 2020 May 11, 2020	BUY	$75.11 - $113.76 $60,238 - $91,235	802 Added 26.92%	3,781 $327,000
Q4 2019 Feb 12, 2020	BUY	$86.8 - $118.57 $258,577 - $353,220	2,979 New	2,979 $320,000

Others Institutions Holding NBIX

# of Institutions

655

Shares Held

96.6M

Call Options Held

282K

Put Options Held

281K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Account

Teza Capital Management LLC Neurocrine Biosciences Inc Transaction History